2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus
{{output}}
Current therapies for systemic lupus erythematosus that target a particular factor or cell type exhibit limited effectiveness. To address this limitation, our focus was on CD132, a subunit common to six inflammatory factor receptors implicated in SLE. Our stud... ...
